Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HRMY
HRMY logo

HRMY News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

HRMY News

Harmony Biosciences Shares Rise on Patent Litigation News

4d agoseekingalpha

Harmony Biosciences Sues AET Pharma Over Patent Infringement

4d agostocktwits

Wall Street Analysts Adjust Ratings

Feb 25 2026Benzinga

Harmony Biosciences Q4 2025 Earnings Highlights

Feb 24 2026seekingalpha

Harmony Biosciences Q4 Earnings Analysis

Feb 24 2026seekingalpha

Harmony Biosciences Reports $868.5 Million Revenue for 2025, Guidance for 2026 Exceeds $1 Billion

Feb 24 2026Newsfilter

Harmony Biosciences Downgraded, Shares Drop 10%

Feb 23 2026seekingalpha

Harmony Biosciences to Announce Q4 Earnings on February 24

Feb 23 2026seekingalpha

HRMY Events

04/21 12:30
Harmony Biosciences Shares Rise to $34.35
Harmony Biosciences shares in midday trading are up $4.88 to $34.35.
04/21 12:30
Mizuho Says Harmony Biosciences Files New Patent Lawsuit
Mizuho analyst Graig Suvannavejh says the firm has learned of a new patent lawsuit filed by Harmony Biosciences against AET Pharma, the sole remaining generic challenger that has yet to settle. Harmony's new lawsuit alleges infringement of a patent covering an amorphous formulation of pitolisant, which was recently licensed by Harmony, the analyst tells investors in a research note. Mizuho now believes Harmony's Wakix franchise should be viewed as "protected and fully intact" until 2030. The firm views the lawsuit as a "significant development" and "major positive" for the company. It should help remove a "major stock overhang" stemming from concerns around a generic coming well before 2030, contends Mizuho. The firm reiterates a an Outperform rating on the shares with a $50 price target.

HRMY Monitor News

Harmony Biosciences Shares Surge on Patent Litigation News

Apr 21 2026

Harmony Biosciences Receives FDA Approval for Wakix in Pediatric Patients

Feb 20 2026

HRMY Earnings Analysis

No Data

No Data

People Also Watch